About Trajenta Linagliptin Tablet
Experience the magnificence of Trajenta Linagliptin Tablets, a top-rated oral hypoglycemic agent for adults with type 2 diabetes mellitus. Formulated with lustrous Linagliptin 5 mg, each round, light red tablet (imprint: D5) enhances glycemic control with a stellar safety profile. Available in blister packs, each box contains 30 tablets manufactured by Boehringer Ingelheim India Pvt. Ltd. Enjoy instant checkout and attractive sale offers with a minimum order of 10 boxes. Designed for convenient once-daily administration, Trajenta brings trusted efficacy for antidiabetic therapy. Prescription required.
Advanced Features & Benefits
Trajenta Linagliptin Tablet offers adults a superb antidiabetic solution with the advantage of a Dipeptidyl Peptidase-4 inhibitor. Its extra feature lies in the low risk of hypoglycemia and convenient oral administration. With a lustrous light red round design and easy-to-monitor 5 mg imprint, the tablet ensures accurate usage. Suitable for daily or as-prescribed dosing, it boasts a long 24-month lifespan and is securely packed in a blister pack to preserve potency.
Domestic Reach & Export Capabilities
Trajenta Linagliptin Tablet is a prominent choice across the Indian domestic market, with reliable supply ability and swift express shipping options available. As a trusted supplier, exporter, and trader, we ensure efficient transportation nationwide and to leading export markets. Rest assured of timely deliveries and high-standard storage throughout the supply chain, supporting seamless distribution. Our focus on quality ensures every shipment meets rigorous export standards.
FAQ's of Trajenta Linagliptin Tablet:
Q: How should Trajenta Linagliptin Tablet be administered for best results?
A: Trajenta Linagliptin Tablet should be taken orally, once daily or exactly as directed by your physician, to achieve optimal glycemic control in adults with type 2 diabetes.
Q: What makes Trajenta Linagliptin a top-rated choice for diabetes management?
A: Its stellar efficacy in improving glycemic control, convenience of oral tablet form, low risk of hypoglycemia, and trusted formulation by Boehringer Ingelheim make Trajenta a leading option for adult patients.
Q: What precautions should be followed during storage?
A: Store Trajenta Linagliptin Tablets in a cool, dry place away from sunlight to maintain their potency and ensure a 24-month shelf life from the manufacturing date.
Q: Where is Trajenta Linagliptin Tablet supplied and exported from?
A: The tablet is supplied domestically across India and exported globally, ensuring express shipping and reliable transportation by Boehringer Ingelheim India Pvt. Ltd.
Q: What is the process to place an order and what is the minimum quantity required?
A: Orders can be placed for a minimum of 10 boxes, each containing 30 tablets, through instant checkout for swift processing. A valid prescription from your physician is required.